There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...

Groundbreaking research presented today at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) ...

A new survey shows that most people would rather try dieting to lose weight than take the latest injectable drugs like ...

The average workplace health insurance plan costs more than $25,000 amid rising prices and expensive weight-loss drugs such ...

GlucoRedi is a supplement product that helps control blood sugar levels. It has a compelling blend of organic antioxidants ...

If you're like the vast majority of individual investors, you've never heard of Scholar Rock, apitegromab, or the ...

Three Fool.com contributors have identified what they believe are no-brainer growth stocks to buy in October. Here's why they picked Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex ...

Nearly two-thirds (64%)  of Americans who have tried weight loss injections report the drugs as being "extremely effective" ...

The former immigration minister, who lost four stone in 12 months, said the drug had aided him at the start of his bid to ...

The National Institutes of Health has launched a nationwide consortium to address the dramatic rise in youth diagnosed with type 2 diabetes over the past two decades, a trend that is expected to ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other best stocks to buy ...